Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies

NCT04001517 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia With Lewy Bodies (DLB)

Interventions

DRUG: Neflamapimod

Sponsor

EIP Pharma Inc

Collaborators

[object Object]